GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » SLS BIO Co Ltd (XKRX:246250) » Definitions » Equity-to-Asset

SLS BIO Co (XKRX:246250) Equity-to-Asset : 0.75 (As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is SLS BIO Co Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. SLS BIO Co's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ₩13,226 Mil. SLS BIO Co's Total Assets for the quarter that ended in Mar. 2024 was ₩17,567 Mil. Therefore, SLS BIO Co's Equity to Asset Ratio for the quarter that ended in Mar. 2024 was 0.75.

The historical rank and industry rank for SLS BIO Co's Equity-to-Asset or its related term are showing as below:

XKRX:246250' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.57   Med: 0.65   Max: 0.76
Current: 0.75

During the past 9 years, the highest Equity to Asset Ratio of SLS BIO Co was 0.76. The lowest was 0.57. And the median was 0.65.

XKRX:246250's Equity-to-Asset is ranked better than
72.77% of 235 companies
in the Medical Diagnostics & Research industry
Industry Median: 0.58 vs XKRX:246250: 0.75

SLS BIO Co Equity-to-Asset Historical Data

The historical data trend for SLS BIO Co's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SLS BIO Co Equity-to-Asset Chart

SLS BIO Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only 0.37 0.35 0.35 0.57 0.76

SLS BIO Co Quarterly Data
Sep22 Dec22 Jun23 Sep23 Dec23 Mar24
Equity-to-Asset Get a 7-Day Free Trial 0.57 0.65 0.64 0.76 0.75

Competitive Comparison of SLS BIO Co's Equity-to-Asset

For the Diagnostics & Research subindustry, SLS BIO Co's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SLS BIO Co's Equity-to-Asset Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, SLS BIO Co's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where SLS BIO Co's Equity-to-Asset falls into.



SLS BIO Co Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

SLS BIO Co's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )=Total Stockholders Equity/Total Assets
=13466.227/17837.584
=0.75

SLS BIO Co's Equity to Asset Ratio for the quarter that ended in Mar. 2024 is calculated as

Equity to Asset (Q: Mar. 2024 )=Total Stockholders Equity/Total Assets
=13225.723/17567.099
=0.75

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


SLS BIO Co  (XKRX:246250) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


SLS BIO Co Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of SLS BIO Co's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


SLS BIO Co (XKRX:246250) Business Description

Traded in Other Exchanges
N/A
Address
Gwanggyo Central Biz Tower, 7th floor, Changryong-dong 260, Gyeonggi-do, Suwon-si, KOR, 16229
SLS BIO Co Ltd is engaged in providing drug development supporting services and pharmaceutical product QC through general tests and assays and instrumental analysis.

SLS BIO Co (XKRX:246250) Headlines

No Headlines